Evidence map›Paper›PMID 31478162›Full record

ArticleEndocrine2019

Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAF

Yuji Nagayama, Hiroyuki Mishima

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yuji NagayamaDepartment of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. nagayama@nagasaki-u.ac.jp.ORCID http://orcid.org/0000-0002-5058-9349
Hiroyuki MishimaDepartment of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Nagasaki University · JPUniversity of Nagasaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePapillary thyroid cancers (PTCs) are the most common type of thyroid cancers, in which BRAF

methodsThe publicly available RNA-seq data for 26 classical (c) and 5 follicular variant (fv) PTCs with BRAF

resultsWe found four lines of evidence for heterogeneity of cPTCs. First, the cluster dendrogram and principle component analyses could not completely distinguish the cancer tissues from normal tissues. Second, the DEGs identified in each sample were highly diverse from one another. Third, although the DEGs were enriched in many terms containing the word "extracellular" ("extracellular region", "extracellular space", and so on) when analyzed as groups, the degree of this enrichment was variable when analyzed individually. Fourth, there are only a few intersections in the over-/underexpressed genes annotated with the terms containing the word "extracellular" among the samples examined. Essentially same results were obtained with BRAF-like, fvPTCs with BRAF

conclusionGroups of BRAF-like, BRAF

Indexed as

Gene ExpressionHumansPrincipal Component AnalysisProto-Oncogene Proteins B-rafThyroid Cancer, PapillaryThyroid NeoplasmsBRAF protein, humanProto-Oncogene Proteins B-rafDifferentially expressed genesHeterogeneityRNA-seqThyroid cancer

Identifiers

PMID31478162
OpenAlexW2972007569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.